ARAAX
Price
$27.10
Change
+$0.09 (+0.33%)
Updated
Dec 3 closing price
Net Assets
1.41B
HCYIX
Price
$18.80
Change
+$0.05 (+0.27%)
Updated
Dec 3 closing price
Net Assets
130.24M
Interact to see
Advertisement

ARAAX vs HCYIX

Header iconARAAX vs HCYIX Comparison
Open Charts ARAAX vs HCYIXBanner chart's image
Horizon Active Risk Assist® A
Price$27.10
Change+$0.09 (+0.33%)
VolumeN/A
Net Assets1.41B
Hilton Tactical Income Instl
Price$18.80
Change+$0.05 (+0.27%)
VolumeN/A
Net Assets130.24M
ARAAX vs HCYIX Comparison Chart in %
View a ticker or compare two or three
VS
ARAAX vs. HCYIX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAAX is a StrongBuy and HCYIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ARAAX has more cash in the bank: 1.41B vs. HCYIX (130M). HCYIX pays higher dividends than ARAAX: HCYIX (3.92) vs ARAAX (0.46). ARAAX was incepted earlier than HCYIX: ARAAX (10 years) vs HCYIX (12 years). ARAAX (1.43) is less costly to investors than HCYIX (1.27). HCYIX is a more actively managed with annual turnover of: 83.00 vs. ARAAX (66.00). ARAAX has a lower initial minimum investment than HCYIX: ARAAX (2500) vs HCYIX (50000). HCYIX annual gain was more profitable for investors over the last year : 5.98 vs. ARAAX (-1.13). HCYIX return over 5 years is better than : 31.02 vs. ARAAX (25.35).
ARAAXHCYIXARAAX / HCYIX
Total Expense Ratio1.431.05136%
Annual Report Gross Expense Ratio1.431.27113%
Fund Existence10 years12 years-
Gain YTD12.5217.744162%
Front LoadN/AN/A-
Min. Initial Investment2500500005%
Min. Initial Investment IRAN/AN/A-
Net Assets1.41B130M1,086%
Annual Yield % from dividends0.463.9212%
Returns for 1 year-1.135.98-19%
Returns for 3 years32.5425.41128%
Returns for 5 years25.3531.0282%
Returns for 10 years45.5565.3570%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRIAX34.64N/A
N/A
Principal Glb Emerging Markets A
WFSAX29.53N/A
N/A
Allspring Small Company Growth A
PJHRX37.37N/A
N/A
PGIM Jennison Health Sciences R
TGVYX64.23N/A
N/A
Touchstone Dynamic Large Cap Growth Y
EEMEX10.06N/A
N/A
MFS Emerging Markets Equity Research R2